Dr. Oak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 First Avenue
New York, NY 10016
Education & Training
NYU Grossman School of MedicineResidency, Neurology, 2020 - 2024- NYU Grossman School of MedicineResidency, Internal Medicine, 2020 - 2021
Washington University in St. Louis School of MedicineClass of 2020
Certifications & Licensure
NY State Medical License 2024 - 2026
Publications & Presentations
PubMed
- 5 citationsMinimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I studySagun D. Goyal, Eunhye Oak, Jingqin Luo, Amanda F. Cashen, Kenneth R. Carson
Leukemia & Lymphoma. 2018-02-01 - 54 citationsPredictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study.Narendranath Epperla, Mehdi Hamadani, Amanda F. Cashen, Kwang Woo Ahn, Eunhye Oak
Hematological Oncology. 2017-01-08 - 37 citationsDe novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohortLapo Alinari, Alejandro A. Gru, Carl Quinion, Ying Huang, Arletta Lozanski
American Journal of Hematology. 2016-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
